All Articles
Late-Breaking HOPA News: Redefining Relapse: What MajesTEC-3 Means for the Treatment of Multiple Myeloma
Sanja Zepcan, PharmD, BCPS, BCOP, and Emily Rux, PharmD, BCOP, discuss the clinical questions raised by the recent MajesTEC-3 trial and the potential changes it finds in the treatment of multiple myeloma.
Pharmacist's Application to Practice: Pirtobrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Cristina V. Martinez, PharmD, PGY2 Oncology Pharmacy Resident, and Hunter Sowell, PharmD, BCOP, Clinical Pharmacy Specialist Oncology, analyze the potential role for pirtobrutinib in treating chronic lymphocytic leukemia and small lymphocytic lymphoma.
Pharmacy Students and Oncology Pharmacists Combat Cancer Misinformation with National Initiative
The Hematology/Oncology Pharmacy Association (HOPA) is proud to team up with the Student National Pharmaceutical Association (SNPhA) for the Cancer Clarity Challenge, a new national competition.
Late-Breaking HOPA News: NeoADAURA: Advancing Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC
Wai Tak Vince Sung, PharmD, MBA, BCOP, BCSCP, breaks down the results from the NeoADAURA trial and what its findings may mean for neoadjuvant osimertinib's role in the treatment of resectable EGFR-mutated NSCLC.
As 2026 Forges Ahead, A Look Back at HOPA in 2025
2025 certainly brought challenges both new and familiar to HOPA, our members, our patients, and those dear to them. But it's also brought hope. It's brought progress. And it's brought an inspiring sense of purpose, passion, and community.
Proposed Student Loan Limits for Nursing and Other Professions Will Contribute to Healthcare Worker Shortages
HOPA is concerned about the Department of Education's proposed language and student loan limits for professions crucial to oncology care, especially nursing. Implementation will contribute to the shortage of healthcare workers in this country.
Pharmacist's Application to Practice: Taletrectinib
Benjamin Pastore, PharmD, PGY2 Adult Oncology Pharmacy Resident, and Jasmine Patel, PharmD, BCOP, Clinical Pharmacy Specialist - Thoracic Oncology, discuss the potential role of taletrectinib in the treatment of metastatic non-small cell lung cancer.
Pharmacist's Application to Practice: Zongertinib
Reyam Katchi, PharmD, PGY2 Hematology/Oncology Pharmacy Resident, and Kiera Roubal, PharmD, Oncology Clinical Pharmacist, break down the potential role for zongertinib in the treatment of non-squamous NSCLC with HER2 TKD activating mutations.
Work-Life Harmony Isn’t About Perfection; It’s About Priorities and Support
Striking the balance between work and family is challenging, but with the right mindset and support, it is possible. And when we succeed, we not only become better parents but also better pharmacists, leaders, and colleagues.
The Impacts of Strong Professional Relationships Between Clinical Pharmacists and Medical Science Liaisons
In this piece from the HOPA News archives, authors Megan Langer and Jake Hanlin reflect on how medical science liaisons have impacted their patient care and professional careers - and what tips they have for productively working with them.